Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rhythm Pharmaceuticals (RYTM) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Rhythm Pharmaceuticals (RYTM) over the last 5 years, with Q3 2025 value amounting to 0.21.

  • Rhythm Pharmaceuticals' Debt Ratio changed N/A to 0.21 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.21, marking a year-over-year change of. This contributed to the annual value of 0.28 for FY2024, which is 1224.46% down from last year.
  • According to the latest figures from Q3 2025, Rhythm Pharmaceuticals' Debt Ratio is 0.21.
  • Rhythm Pharmaceuticals' 5-year Debt Ratio high stood at 0.32 for Q4 2023, and its period low was 0.21 during Q3 2025.
  • In the last 3 years, Rhythm Pharmaceuticals' Debt Ratio had a median value of 0.28 in 2025 and averaged 0.28.
  • Over the last 5 years, Rhythm Pharmaceuticals' Debt Ratio had its largest YoY gain of 1224.46% in 2024, and its largest YoY loss of 1224.46% in 2024.
  • Rhythm Pharmaceuticals' Debt Ratio (Quarter) stood at 0.32 in 2023, then dropped by 12.24% to 0.28 in 2024, then fell by 23.2% to 0.21 in 2025.
  • Its last three reported values are 0.21 in Q3 2025, 0.29 for Q2 2025, and 0.28 during Q1 2025.